IgG4 promotes colon cancer progression by inducing tolerogenic M2-like macrophages via FcγRI and PI3K/AKT/STAT3 signaling, leading to an immunosuppressive tumor microenvironment (51). The gene discussed is STAT3; the disease is neoplasm.